会员登录 - 用户注册 - 设为首页 - 加入收藏 - 网站地图 【how to dismount c/fd teleconverter】American Assets Trust Inc (AAT) Chairman, CEO & President Ernest S Rady Bought $430,471 of ...!

【how to dismount c/fd teleconverter】American Assets Trust Inc (AAT) Chairman, CEO & President Ernest S Rady Bought $430,471 of ...

时间:2024-09-29 12:28:44 来源:k 3 i y 3 0 o n 4 k s e 6 p l 8 o i t c j q 作者:Encyclopedia 阅读:968次

- By insider

Chairman,how to dismount c/fd teleconverter CEO & President of American Assets Trust Inc (

【how to dismount c/fd teleconverter】American Assets Trust Inc (AAT) Chairman, CEO & President Ernest S Rady Bought $430,471 of ...


AAT

【how to dismount c/fd teleconverter】American Assets Trust Inc (AAT) Chairman, CEO & President Ernest S Rady Bought $430,471 of ...


)

【how to dismount c/fd teleconverter】American Assets Trust Inc (AAT) Chairman, CEO & President Ernest S Rady Bought $430,471 of ...


Ernest S Rady


bought 10,805 shares of AAT on 12/31/2018 at an average price of $39.84 a share. The total cost of this purchase was $430,471.


American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company mainly invests in, operates, and develops retail, office, residential, and mixed-use properties in California, Oregon, and Hawaii. American Assets Trust Inc has a market cap of $1.86 billion; its shares were traded at around $39.30 with a P/E ratio of 91.38 and P/S ratio of 7.00. The dividend yield of American Assets Trust Inc stocks is 2.76%. American Assets Trust Inc had annual average EBITDA growth of 2.90% over the past five years.


Warning! GuruFocus has detected 8 Warning Signs with AAT. Click here to check it out.


AAT 15-Year Financial Data


The intrinsic value of AAT


Peter Lynch Chart of AAT


CEO Recent Trades:


Chairman, CEO & President, 10% Owner


Ernest S Rady


bought 10,805 shares of AAT stock on 12/31/2018 at the average price of $39.84. The price of the stock has decreased by 1.36% since.


Chairman, CEO & President, 10% Owner


Ernest S Rady


bought 4,326 shares of AAT stock on 12/27/2018 at the average price of $38.65. The price of the stock has increased by 1.68% since.


Directors and Officers Recent Trades:


Director


Duane Nelles


bought 25,000 shares of AAT stock on 12/04/2018 at the average price of $41.74. The price of the stock has decreased by 5.85% since.


For the complete insider trading history of AAT,


click here


.This article first appeared on GuruFocus.


Warning! GuruFocus has detected 8 Warning Signs with AAT. Click here to check it out.


AAT 15-Year Financial Data


The intrinsic value of AAT


Peter Lynch Chart of AAT


View comments


(责任编辑:Encyclopedia)

相关内容
  • Iran watchdog passes law on hardening nuclear stance, halting UN inspections
  • FITB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 8, 2020 in the Class Action Filed on Behalf of Fifth Third Bancorp Limited Shareholders
  • Trump threatens to deploy U.S. military to quell riots across the country
  • RTX CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Raytheon Technologies Corporation
  • Where Do Hedge Funds Stand On Pacific Mercantile Bancorp (PMBC)?
  • Best Tarot Cards Reading Online By Kasamba Tarot Readers Experts - How To get Free Love Tarot Readings Online
  • California ballot initiative on gig workers could be among costliest in state's history
  • Manufacturing data helps lift stocks, U.S. dollar bounces
推荐内容
  • Insights on the Surgical Sealant/Tissue Patch Global Market to 2025 - Key Drivers and Restraints
  • TUI Strikes Compensation Deal With Boeing Over 737 MAX Jets
  • Brazil manufacturing PMI rises to 38.3 in May from record low 36.0 in April - IHS Markit
  • Hedge Funds Aren’t Done Buying Tech Data Corp (TECD)
  • Trintech Extends Reporting Capabilities in Its Adra Suite with the Launch of Adra Analytics
  • United Kingdom Cardiac Rhythm Management Devices Market Outlook to 2025 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers